Recent advances in UroLift: A comprehensive overview

Denisenko, Andrew; Somani, Bhaskar; Agrawal, Vikesh

doi:10.5152/tud.2022.21149

Cited by 4 publications

(9 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This hyperplasia causes a benign enlargement of the glandular tissue surrounding the prostatic urethra, leading to bladder outlet obstruction and subsequent LUTS [ 1 ]. These symptoms can include incomplete emptying of the bladder, urinary retention, frequency, urgency, incontinence, sexual dysfunction, nocturia, and UTIs [ 1 , 3 ]. Treatment for BPH will depend on the severity of the patient's symptoms [ 1 ].…”

Section: Introductionmentioning

confidence: 99%

“…The US FDA granted approval for UroLift 10 years ago. UroLift has gained worldwide popularity due to the favorable surgical outcomes, decreased recovery time, and diminished side effects compared to other surgical approaches [ 3 ]. So far, worldwide, more than 400,000 patients have been treated with UroLift [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

“…So far, worldwide, more than 400,000 patients have been treated with UroLift [ 4 ]. Several studies have been performed to evaluate the outcomes of patients after UroLift placement [ 3 ]. Results of these studies show that most patients have marked improvement in quality of life and the International Prostate Symptom Score (IPSS), reduction in LUTS, and no deficiencies in erectile or ejaculatory function [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Pelvic Hematoma After UroLift: A Case Report and Literature Review

Rodríguez-Fernández¹,

Bernaschina-Bobadilla²

2023

Cureus

View full text Add to dashboard Cite

UroLift is a novel, minimally invasive surgical technique used to treat bladder outlet obstruction due to benign prostatic hyperplasia (BPH). UroLift was granted US FDA approval in 2013, and so far, it has gained acceptance and popularity worldwide. In this case report, we present a 69-year-old male patient that developed a pelvic hematoma with subacute clinical manifestations two months following UroLift. The patient was managed conservatively, resulting in the complete resolution of the hematoma. As more surgeons are trained, and the caseload increases, we expect to see more complications related to this novel technique. Surgeons should be aware of this procedure's potential short- and long-term complications.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pelvic Hematoma After UroLift: A Case Report and Literature Review

Rodríguez-Fernández¹,

Bernaschina-Bobadilla²

2023

Cureus

View full text Add to dashboard Cite

show abstract

“…9,10 'UroLift' implants are an increasingly utilised means of relieving obstructive urethral symptoms arising from benign prostatic hyperplasia. [11][12][13] This minimally invasive surgery involves the insertion of four implants, each comprising two brackets connected by a suture as seen in Figure 1. One bracket embeds in the prostatic capsule, while the other stays in the urethra lumen; the resulting combined strain from the sutures opens the prostate lumen.…”

Section: Introductionmentioning

confidence: 99%

“…One bracket embeds in the prostatic capsule, while the other stays in the urethra lumen; the resulting combined strain from the sutures opens the prostate lumen. UroLift implantation causes minor and short-lasting (1-month) occasional side effects of irritation, dysuria and haematuria, 11 does not require hospital admission and has been shows to improve sexual function 14 compared to transurethral resection of the prostate.…”

Section: Introductionmentioning

confidence: 99%

UroLift implants as surrogate fiducial markers for cone-beam CT-based prostate image-guided radiotherapy

et al. 2023

View full text Add to dashboard Cite

Introduction: UroLift implants are a novel treatment for the obstructive lower urinary tract symptoms arising from benign prostatic hyperplasia. This case study aimed to assess their effectiveness as fiducial marker (FM) surrogates in prostate image-guided radiotherapy (IGRT). Method: Cone-beam CT images from a patient receiving prostate radiation therapy underwent manual alignment using UroLift implants and also prostate soft-tissue matching by five experienced therapeutic radiographers. The match values of both methods were compared using Bland–Altman analysis. All five observers were also asked to score the ease of matching using both approaches. Results: The 95% mean level of agreement for the UroLift matches were within a 2-mm threshold in all dimensions. Comparison of UroLift and prostate matches had 95% limit of agreement values of −0·98 to 1·78, −0·58 to 0·49 and −1·83 to 1·04 mm in the vertical, longitudinal and lateral planes, respectively. All of the UroLift matches were rated as ‘very easy’ or ‘possible with little difficulty’ by the five observers. Conclusion: A small difference between the CBCT UroLift and CBCT prostate match was found. It has been shown that IGRT to the prostate with the aid of the UroLift system implants and CBCT is feasible and can eliminate the need for FM implants. Wider evaluation in a large cohort is recommended.

show abstract

Bilateral Knee Septic Arthritis after Prostatic Urethral Lift: A Case Report

Goodsell¹,

Lewis²,

Domanski³

2023

JOCR

View full text Add to dashboard Cite

Introduction: Septic arthritis (SA) is a rare clinical entity that can lead to significant morbidity and mortality. Recent years have seen a rise in minimally invasive surgical therapy for the treatment of benign prostatic hyperplasia, including prostatic urethral lift. We report a case of bilateral simultaneous SA of the knees, following a prostatic urethral lift procedure. SA following a urologic procedure has not previously been reported. Case Report: A 79-year-old male presented to the Emergency Department through an ambulance with bilateral knee pain with associated fever and chills. Two weeks before presentation, he had undergone a prostatic urethral lift, cystoscopy, and Foley catheter placement. The examination was remarkable for bilateral knee effusions. Arthrocentesis was performed, and the synovial fluid analysis was consistent with a diagnosis of SA. Conclusion: This case emphasizes the need for frontline clinicians to consider SA in patients presenting with joint pain as a rare complication of prostatic instrumentation. Keywords: Septic arthritis, knee joint, prostatic urethral lift.

show abstract

Recent advances in UroLift: A comprehensive overview

Cited by 4 publications

References 24 publications

Pelvic Hematoma After UroLift: A Case Report and Literature Review

Pelvic Hematoma After UroLift: A Case Report and Literature Review

UroLift implants as surrogate fiducial markers for cone-beam CT-based prostate image-guided radiotherapy

Bilateral Knee Septic Arthritis after Prostatic Urethral Lift: A Case Report

Contact Info

Product

Resources

About